Advanced Oxygen Technologies, Inc.

Advanced Oxygen Technologies, Inc.

AOXY
Advanced Oxygen Technologies, Inc.US flagOther OTC
0.10
USD
-0.01
- -
322,709.00Market Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
0.03
0.02
0.02
0.02
0.02
0.02
0.02
0.01
0.01
0.01
0.01
0.01
0.01
0.01
Basic EPS, GAAP
0.01
-0.03
0.01
- -
- -
- -
- -
-0.03
- -
0.02
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
-0.04
- -
-0.01
0.01
0.02
0.01
0.01
0.01
0.03
0.01
0.01
0.01
0.02
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
-8.83
-8.85
-9.04
-9.04
-9.04
-9.03
-9.03
-6.79
-6.31
-6.3
-6.3
-6.29
-6.29
-6.29
Tangible Book Value per Share
0.11
0.08
0.11
0.12
0.13
0.13
0.13
0.1
0.11
0.1
0.11
0.1
0.13
0.12
Basic Weighted Avg Shares
2
2
2
2
2
2
2
3
3
3
3
3
3
3
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Operating Margin (%)
55.69
-136.11
60.66
65.93
42.41
51.46
49.92
-213.21
40.26
33.1
28.43
33.94
31.7
30.19
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
31.59
- -
- -
29.41
99.9
49.13
45.9
- -
58.93
12.38
78.23
62.27
70.7
75.29
Profit Margin (%)
54.44
-144.82
47.08
30.42
0.03
18.75
21.12
-238.92
13.87
144.23
5.76
13.07
9.52
7.46
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
4.63
- -
- -
2.88
- -
1.81
1.86
- -
1.25
2.1
0.46
1
0.69
0.56
Return on Capital (%)
-0.18
- -
- -
-0.08
- -
-0.05
-0.05
- -
-0.03
-0.28
-0.01
-0.03
-0.02
-0.02
Return on Common Equity (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -

Capital Structure

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
ST Debt
- -
- -
- -
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
3
3
3
Market Capitalization
- -
- -
- -

Working Capital

FRC

in mil. unless spec.
Sep'26
Dec'26
Mar'26
Total Current Assets
- -
- -
- -
Cash, Cash Equivalents & STI
- -
- -
- -
Accounts Receivable, Net
- -
- -
- -
Inventories
- -
- -
- -
Total Current Liabilities
- -
- -
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
- -
- -
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
5.08%
6.85%
21.55%
Free Cash Flow
-75.68%
19.58%
-10.42%
Net Income, GAAP
8,205.25%
161.93%
-25.63%
Sales/Revenue/Turnover
1.39%
0.24%
2.04%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

APIChat
CEO
Robert E. Wolfe
Full Time Employees
2
Sector
Real Estate
Industry
Real Estate - Services
Address
653 VT Route 12A Randolph VT United States of America 05060
IPO Date
Jul 16, 1981
Business
Advanced Oxygen Technologies, Inc. (AOXY) develops and commercializes advanced oxygen-related technologies for medical, industrial, and environmental applications. The company offers portable oxygen concentrators, oxygen generation systems, and related accessories, including models such as the AOT OM-1 and OM-2 portable units designed for therapeutic use; stationary oxygen concentrators for home and clinical settings; and industrial oxygen solutions for applications like aquaculture, wastewater treatment, and ozone generation. These products utilize proprietary pressure swing adsorption (PSA) technology to produce high-purity oxygen efficiently, targeting healthcare providers, patients with respiratory conditions, industrial manufacturers, and environmental service companies primarily in Canada and the United States. Founded in 2019 and headquartered in Richmond, British Columbia, Canada, the company operates through its primary website at www.aoxy-ca.com and focuses on North American markets with potential expansion into Asia-Pacific regions. In late 2024, Advanced Oxygen Technologies announced a strategic partnership with a leading Canadian healthcare distributor to expand distribution of its OM-series portable concentrators across Western Canada, enhancing market penetration. Additionally, in Q3 2025, the company completed a $2.5 million private placement funding round led by existing institutional investors to support R&D for next-generation lightweight concentrators and production scaling; it also launched the AOT Pro Industrial series for aquaculture oxygen enrichment, marking entry into the commercial farming segment.

Company News

APIChat
  • Critical Contrast: Derwent Valley (OTCMKTS:DWVYF) vs. Advanced Oxygen Technologies (OTCMKTS:AOXY)